- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Pharma still in waiting mode after UK-US trade agreement | ||
| 08.05. | FDA announces generative AI pilot and rapid rollout plans | ||
| 08.05. | Boehringer advances oral therapy for geographic atrophy | ||
| 08.05. | Gilead ups its US investment plans by $11 billion | ||
| 08.05. | Spectre of 'favoured nation' pricing manifests again in US | ||
| 08.05. | Shionogi aims to buy tobacco giant's pharma unit for $1bn | ||
| 08.05. | RFK Jr launches database project to explore autism causes | ||
| 07.05. | New data could move Enhertu into early breast cancer | ||
| 07.05. | UK trumpets a trade deal with India - but pharma isn't happy | ||
| 07.05. | AI trained on NHS data 'may predict ill health in advance' | ||
| 07.05. | FDA ramps up unannounced inspections of foreign facilities | ||
| 07.05. | Vinay Prasad will replace Marks as CBER director | ||
| 06.05. | Trump backs Biden-era abortion pill defence | ||
| 06.05. | Despite US turmoil, Hinge Health pushes ahead with IPO | ||
| 06.05. | Lilly forges a $415m ALS alliance with UK biotech Alchemab | ||
| 06.05. | EU joins the bid to court beleaguered US scientists | ||
| 06.05. | PTC's Huntington study was positive. Why did its stock fall? | ||
| 05.05. | FDA decision on oral Wegovy coming in Q4 | ||
| 05.05. | Can other countries entice US scientists hit by Trump cuts? | ||
| 05.05. | Trump's budget would be "catastrophic" for federal R&D | ||
| 02.05. | Trials set up filings for AZ's triple therapy in asthma | ||
| 02.05. | FDA resurrects Satsuma's nasal migraine treatment | ||
| 02.05. | Lilly hit as PBM drops Zepbound, but retains Wegovy | ||
| 02.05. | Backers submit plans for £1bn cancer district in London | ||
| 02.05. | NIH is pulling the plug on foreign research grants |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .